nivolumab pancreatic cancer fda approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nivolumab pancreatic cancer fda approval	0.33	0.8	8277	39	40
nivolumab	0.53	0.3	9915	61	9
pancreatic	1.43	0.3	7095	6	10
cancer	1.43	0.4	9545	17	6
fda	0.05	0.1	9528	14	3
approval	0.16	0.9	4035	11	8

Keyword	CPC	PCC	Volume	Score
nivolumab pancreatic cancer fda approval	1.14	0.6	3232	48
nivolumab pancreatic cancer trial	1	0.5	7472	62
nivolumab pancreatic cancer treatment	0.8	0.1	9011	53
nivolumab gastric cancer fda approval	1.03	0.4	6758	46
nivolumab pancreatic cancer nejm	1.21	0.5	4378	42
fda approval of nivolumab	1.78	0.6	1442	61
nivolumab pancreatic cancer immunotherapy	1.03	0.5	7767	43
nivolumab pancreatic cancer results	1.81	0.5	1962	75
nivolumab fda approval date	1.25	0.4	7581	29
nivolumab fda approval history	1.69	1	447	72
nivolumab fda approval nsclc	1.7	1	8816	78
small cell lung cancer nivolumab fda approval	1.15	0.6	2299	59
when was nivolumab fda approved	0.54	0.1	1712	84
nivolumab pancreatic cancer survival	0.26	0.7	8188	62
nivolumab for the treatment of cancer	0.83	0.3	5087	23
nivolumab fda approved indications	1.53	0.5	1625	69
nivolumab for gastric cancer	1.1	0.6	2502	33
when was nivolumab approved	0.37	0.4	9338	53
ipilimumab nivolumab combination fda approval	1.99	0.1	6237	96
nivolumab for liver cancer	0.76	0.9	6938	66
nivolumab ipilimumab nsclc fda	0.62	0.1	4230	50
nivolumab and fda indications	1.98	0.8	1156	15
nivolumab fda package insert	0.68	0.9	4595	30
nivolumab for kidney cancer	1.31	0.1	883	59
nivolumab price in usa	1.43	1	139	70
small cell lung cancer nivolumab trial	0.18	1	9519	46
pancreatic cancer clinical trial	1.13	0.8	7962	84
non small cell lung cancer trials nivolumab	1.34	1	3125	92
nih pancreatic cancer trials	0.43	0.5	1988	47